American Enterprise Institute

Discussing GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box”

Senior Fellow Scott Gottlieb discusses GLP-1’s and the drug approval process: Gottlieb on CNBC’s “Squawk Box.” ...
American Enterprise Institute

Discussing the FDA’s new rare disease framework: Gottlieb on CNBC’s ‘Squawk Box’

Senior Fellow Scott Gottlieb discusses the FDA’s new rare disease framework on CNBC’s ‘Squawk Box.’ ...

Dr. Scott Gottlieb: FDA's rare disease framework is 'a very good start'

Former FDA Commissioner Dr. Scott Gottlieb joins "Squawk Box' to discuss the FDA's new framework for accelerating the development of individualized therapies for rare genetic diseases, how the new ...